Marketing-authorisation holder · Netherlands
Merck Sharp & Dohme B.V.
379 medicines in 5 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Netherlands
379 medicines in 5 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 379
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AERINAZE 2,5 MG/120 MG COMPRIMIDOS DE LIBERACION MODIFICADA2,5 mg + 120 mg · Comprimido de liberación modificada | Desloratadine, Pseudoephedrine | Spain | Authorised | 2020 |
| AERIUS 5 MG COMPRIMIDOS BUCODISPERSABLES5 mg · Comprimido bucodispersable | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS BUCODISPERSABLES5 mg · Comprimido bucodispersable | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS BUCODISPERSABLES5 mg · Comprimido bucodispersable | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS BUCODISPERSABLES5 mg · Comprimido bucodispersable | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto | Desloratadine | Spain | Marketed | 2022 |
| AERIUS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto | Desloratadine | Spain | Marketed | 2019 |
| AERIUS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto | Desloratadine | Spain | Authorised | 2016 |
| AERIUS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto con película | Desloratadine | Spain | Marketed | 2015 |
| Bridion | Sugammadex | EU (EMA) | Authorised | 2008 |
| BRIDIONSoluzione iniettabile | Sugammadex | Italy | Authorised | |
| Bridion 100 mg/ml oplossing voor injectieOplossing voor injectie | Sugammadex | Netherlands | Authorised | 2008 |
| BRIDION 100 MG/ML SOLUCION INYECTABLE100 mg · Solución inyectable | Sugammadex | Spain | Marketed | 2008 |
| BRIDION 100 MG/ML SOLUCION INYECTABLE100 mg · Solución inyectable | Sugammadex | Spain | Marketed | 2008 |
| CANCIDASPolvere per concentrato per soluzione per infusione | Caspofungin | Italy | Authorised | |
| Cancidas 50 mg, poeder voor concentraat voor oplossing voor intraveneuze infusieConcentraat voor oplossing voor infusie | Caspofungin | Netherlands | Authorised | 2001 |
| CANCIDAS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION50 mg · Polvo para concentrado para solución para perfusión | Caspofungin | Spain | Marketed | 2002 |
| Cancidas 70 mg, poeder voor concentraat voor oplossing voor intraveneuze infusiePoeder voor oplossing voor injectie | Caspofungin | Netherlands | Authorised | 2001 |
| CANCIDAS 70 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION70 mg · Polvo para concentrado para solución para perfusión | Caspofungin | Spain | Marketed | 2002 |
| Capvaxive | Pneumococcal polysaccharide conjugate vaccine | EU (EMA) | Authorised | 2025 |
| CAPVAXIVESoluzione iniettabile in siringa pre-riempita | Vaccino pneumococcico polisaccaridico coniugato | Italy | Authorised | |
| CAPVAXIVE oplossing voor injectie in een voorgevulde spuit Pneumokokkenpolysacharide-conjugaatvaccin (21-valent)Oplossing voor injectie | Pneumokokken polysaccharide serotype geconjugeerd aan plasmid-afgeleid difterie crm197 carrierproteïne, Pneumokokken polysaccharide serotype deoac geconjugeerd aan plasmid-afgeleid difterie crm197 carrierproteïne | Netherlands | Authorised | 2025 |
| CAPVAXIVE SOLUCION INYECTABLE EN JERINGA PRECARGADA4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis + 4 µg/dosis · Solución inyectable en jeringa precargada | Neumococo antigeno polisacarido capsular serotipo | Spain | Marketed | 2025 |
| CUBICINPolvere per concentrato per soluzione per infusione | Daptomycin | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 170 | 144 | 26 | CompaniesAll medicines |
| Netherlands | 117 | 117 | 0 | CompaniesAll medicines |
| European Union (EMA) | 50 | 40 | 10 | CompaniesAll medicines |
| Italy | 40 | 40 | 0 | CompaniesAll medicines |
| Croatia | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Romania, Saudi Arabia, Serbia
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Other companies in the same group.
Ranked by their number of medicines.